184 related articles for article (PubMed ID: 26941170)
1. Rescue of Synaptic Phenotypes and Spatial Memory in Young Fragile X Mice.
Sun MK; Hongpaisan J; Alkon DL
J Pharmacol Exp Ther; 2016 May; 357(2):300-10. PubMed ID: 26941170
[TBL] [Abstract][Full Text] [Related]
2. Bryostatin-1 restores hippocampal synapses and spatial learning and memory in adult fragile x mice.
Sun MK; Hongpaisan J; Lim CS; Alkon DL
J Pharmacol Exp Ther; 2014 Jun; 349(3):393-401. PubMed ID: 24659806
[TBL] [Abstract][Full Text] [Related]
3. Fragile X mental retardation protein regulates the levels of scaffold proteins and glutamate receptors in postsynaptic densities.
Schütt J; Falley K; Richter D; Kreienkamp HJ; Kindler S
J Biol Chem; 2009 Sep; 284(38):25479-87. PubMed ID: 19640847
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.
Franklin AV; King MK; Palomo V; Martinez A; McMahon LL; Jope RS
Biol Psychiatry; 2014 Feb; 75(3):198-206. PubMed ID: 24041505
[TBL] [Abstract][Full Text] [Related]
5. Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
Henderson C; Wijetunge L; Kinoshita MN; Shumway M; Hammond RS; Postma FR; Brynczka C; Rush R; Thomas A; Paylor R; Warren ST; Vanderklish PW; Kind PC; Carpenter RL; Bear MF; Healy AM
Sci Transl Med; 2012 Sep; 4(152):152ra128. PubMed ID: 22993295
[TBL] [Abstract][Full Text] [Related]
6. Long-term memory deficits are associated with elevated synaptic ERK1/2 activation and reversed by mGluR5 antagonism in an animal model of autism.
Seese RR; Maske AR; Lynch G; Gall CM
Neuropsychopharmacology; 2014 Jun; 39(7):1664-73. PubMed ID: 24448645
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome.
Muddashetty RS; Kelić S; Gross C; Xu M; Bassell GJ
J Neurosci; 2007 May; 27(20):5338-48. PubMed ID: 17507556
[TBL] [Abstract][Full Text] [Related]
8. Visual-spatial learning impairments are associated with hippocampal PSD-95 protein dysregulation in a mouse model of fragile X syndrome.
Gandhi RM; Kogan CS; Messier C; Macleod LS
Neuroreport; 2014 Mar; 25(4):255-61. PubMed ID: 24323121
[TBL] [Abstract][Full Text] [Related]
9. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.
Bhattacharya A; Kaphzan H; Alvarez-Dieppa AC; Murphy JP; Pierre P; Klann E
Neuron; 2012 Oct; 76(2):325-37. PubMed ID: 23083736
[TBL] [Abstract][Full Text] [Related]
10. Reducing eIF4E-eIF4G interactions restores the balance between protein synthesis and actin dynamics in fragile X syndrome model mice.
Santini E; Huynh TN; Longo F; Koo SY; Mojica E; D'Andrea L; Bagni C; Klann E
Sci Signal; 2017 Nov; 10(504):. PubMed ID: 29114037
[TBL] [Abstract][Full Text] [Related]
11. Effects of the sigma-1 receptor agonist blarcamesine in a murine model of fragile X syndrome: neurobehavioral phenotypes and receptor occupancy.
Reyes ST; Deacon RMJ; Guo SG; Altimiras FJ; Castillo JB; van der Wildt B; Morales AP; Park JH; Klamer D; Rosenberg J; Oberman LM; Rebowe N; Sprouse J; Missling CU; McCurdy CR; Cogram P; Kaufmann WE; Chin FT
Sci Rep; 2021 Aug; 11(1):17150. PubMed ID: 34433831
[TBL] [Abstract][Full Text] [Related]
12. 7, 8-Dihydroxyflavone induces synapse expression of AMPA GluA1 and ameliorates cognitive and spine abnormalities in a mouse model of fragile X syndrome.
Tian M; Zeng Y; Hu Y; Yuan X; Liu S; Li J; Lu P; Sun Y; Gao L; Fu D; Li Y; Wang S; McClintock SM
Neuropharmacology; 2015 Feb; 89():43-53. PubMed ID: 25229717
[TBL] [Abstract][Full Text] [Related]
13. Involvement of Phosphodiesterase 2A Activity in the Pathophysiology of Fragile X Syndrome.
Maurin T; Melancia F; Jarjat M; Castro L; Costa L; Delhaye S; Khayachi A; Castagnola S; Mota E; Di Giorgio A; Servadio M; Drozd M; Poupon G; Schiavi S; Sardone L; Azoulay S; Ciranna L; Martin S; Vincent P; Trezza V; Bardoni B
Cereb Cortex; 2019 Jul; 29(8):3241-3252. PubMed ID: 30137253
[TBL] [Abstract][Full Text] [Related]
14. Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice.
Cogram P; Alkon DL; Crockford D; Deacon RMJ; Hurley MJ; Altimiras F; Sun MK; Tranfaglia M
Sci Rep; 2020 Oct; 10(1):18058. PubMed ID: 33093534
[TBL] [Abstract][Full Text] [Related]
15. Proteomics, ultrastructure, and physiology of hippocampal synapses in a fragile X syndrome mouse model reveal presynaptic phenotype.
Klemmer P; Meredith RM; Holmgren CD; Klychnikov OI; Stahl-Zeng J; Loos M; van der Schors RC; Wortel J; de Wit H; Spijker S; Rotaru DC; Mansvelder HD; Smit AB; Li KW
J Biol Chem; 2011 Jul; 286(29):25495-504. PubMed ID: 21596744
[TBL] [Abstract][Full Text] [Related]
16. Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
Gross C; Nakamoto M; Yao X; Chan CB; Yim SY; Ye K; Warren ST; Bassell GJ
J Neurosci; 2010 Aug; 30(32):10624-38. PubMed ID: 20702695
[TBL] [Abstract][Full Text] [Related]
17. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.
Su T; Fan HX; Jiang T; Sun WW; Den WY; Gao MM; Chen SQ; Zhao QH; Yi YH
Psychopharmacology (Berl); 2011 May; 215(2):291-300. PubMed ID: 21181121
[TBL] [Abstract][Full Text] [Related]
18. Fragile X syndrome and targeted treatment trials.
Hagerman R; Lauterborn J; Au J; Berry-Kravis E
Results Probl Cell Differ; 2012; 54():297-335. PubMed ID: 22009360
[TBL] [Abstract][Full Text] [Related]
19. Altered surface mGluR5 dynamics provoke synaptic NMDAR dysfunction and cognitive defects in Fmr1 knockout mice.
Aloisi E; Le Corf K; Dupuis J; Zhang P; Ginger M; Labrousse V; Spatuzza M; Georg Haberl M; Costa L; Shigemoto R; Tappe-Theodor A; Drago F; Vincenzo Piazza P; Mulle C; Groc L; Ciranna L; Catania MV; Frick A
Nat Commun; 2017 Oct; 8(1):1103. PubMed ID: 29062097
[TBL] [Abstract][Full Text] [Related]
20. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
